Success Case: ChemiCare, Bridge4Pharma, and Therapeutic Innovation
30 January 2024
/
From the Bio4Dreams network comes the collaboration between ChemiCare and Bridge4Pharma to enhance the development of innovative therapies.
ChemiCare and Bridge4Pharma have formed a collaboration to enhance the development of innovative therapies already in the pipeline.
ChemiCare is an innovative SME, currently incubated and supported by Bio4Dreams, specializing in the development of drugs for calcium-related diseases, including rare and autoimmune diseases.
Bridge4Pharma, already our partner, is an expert entity in supporting research and development projects and activities, particularly in the diagnostic, therapeutic, and digital device fields.
The collaboration, accompanied by an investment from Bridge4Pharma in ChemiCare, aims to combine resources and expertise to boost the development of innovative therapeutic solutions already in the pipeline.
This close relationship exemplifies how the Bio4Dreams network can facilitate significant connections and mutual support among its members, paving the way for solutions that can truly transform the health and wellness sector.
See ChemiCare’s update on LinkedIn.
Last updates
20 Dec 24
Premio 2031: Bio4Dreams selects the T-SURE project
T-SURE, a project developing a device for abdominal hernia repair, wins the Bio4Dreams award at Premio 2031.
19 Dec 24
Partnering with Sorean to support startups in the Healthcare sector
Bio4Dreams and Sorean collaborate to support innovative health startups with investments, expertise, and qualified networks.
12 Dec 24
BUOONOfarm: urban agriculture startup joins Bio4Dreams
A pioneer in sustainable urban agriculture, the Milan-based startup BUOONOfarm enters the Bio4Dreams ecosystem.